Unknown

Dataset Information

0

Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.

ABSTRACT:

SUBMITTER: Garcia-Fernandez A 

PROVIDER: S-EPMC7528841 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.

García-Fernández Amaya A   Ramos-Ruiz Pablo P   Ibáñez-Criado Alicia A   Moreno-Pérez Óscar Ó   Cambra-Poveda Cristina C   Martínez-Martínez Juan Gabriel JG  

Revista espanola de cardiologia (English ed.) 20201001 1

Similar Datasets

Unknown [Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients].
| S-EPMC7473341 | biostudies-literature
Unknown Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
| S-EPMC7987362 | biostudies-literature
Unknown Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.
| S-EPMC7831445 | biostudies-literature
Unknown Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study.
| S-EPMC7556606 | biostudies-literature
Unknown Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish.
| S-EPMC8164503 | biostudies-literature
Unknown Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study.
| S-EPMC8604637 | biostudies-literature
Unknown Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
| S-EPMC7397242 | biostudies-literature
Unknown QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights.
| S-EPMC7845456 | biostudies-literature
Unknown Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19.
| S-EPMC7563535 | biostudies-literature
Unknown Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
| S-EPMC7406234 | biostudies-literature